TAK
Takeda Pharmaceutical Co ADR
3월 13일 4:00 PM ET (한국 3/14 05:00)
$17.77
+0.00 +0.00%
🌙 3월 13일 6:17 PM ET (한국 3/14 07:17)
$17.77
+0.00 +0.00%
| Index | - | P/E | 73.83 | EPS (ttm) | 0.24 | Insider Own | - | Shs Outstand | 3.16B | Perf Week | -0.62% |
| Market Cap | 56.14B | Forward P/E | 30.64 | EPS next Y | 60.56% | Insider Trans | - | Shs Float | 3.16B | Perf Month | -2.79% |
| Enterprise Value | 82.93B | PEG | 0.73 | EPS next Q | 0.01 | Inst Own | 2.66% | Short Float | 0.22% | Perf Quarter | 23.66% |
| Income | 0.78B | P/S | 1.88 | EPS this Y | 54.04% | Inst Trans | -0.51% | Short Ratio | 2.37 | Perf Half Y | 15.84% |
| Sales | 29.85B | P/B | 1.15 | EPS next 5Y | 42.1% | ROA | 0.8% | Short Interest | 6.98M | Perf YTD | 13.98% |
| Book/sh | 15.43 | P/C | 13.44 | EPS past 3/5Y | -30.04% 11.4% | ROE | 1.62% | 52W High | -5.58% ($18.82) | Perf Year | 18.23% |
| Cash/sh | 1.32 | P/FCF | 9.19 | Sales past 3/5Y | -1.83% -0.14% | ROIC | 1.02% | 52W Low | 36.8% ($12.99) | Perf 3Y | 11.69% |
| Dividend Est. | $0.64 (3.63%) | EV/EBITDA | 9.59 | EPS Y/Y TTM | -42.69% | Gross Margin | 51.7% | Volatility(W/M) | 1.26% 1.3% | Perf 5Y | -3.63% |
| Dividend TTM | 0.32 | EV/Sales | 2.78 | Sales Y/Y TTM | -1.23% | Oper. Margin | 11.79% | ATR (14) | 0.31 | Perf 10Y | -26.87% |
| Dividend Ex-Date | 2025/9/30 | Quick Ratio | 0.65 | EPS Q/Q | 339.12% | Profit Margin | 2.6% | RSI (14) | 46.7 | Recom | 2.07 |
| Dividend Gr. 3/5Y | -4.5% -3.34% | Current Ratio | 1.19 | Sales Q/Q | 3.02% | SMA20 | -2.96% ($18.31) | Beta | 0.03 | Target Price | $18.46 |
| Payout | 242.25% | Debt/Eq | 0.64 | Earnings | 1000000 | SMA50 | 2.29% ($17.37) | Rel Volume | 0.85 | Prev Close | $17.77 |
| Employees | 47455 | LT Debt/Eq | 0.56 | EPS/Sales Surpr. | 56.23% 2.48% | SMA200 | 15.99% ($15.32) | Avg Volume(3M) | 2.94M | Price | $17.77 |
| IPO | 2008/3/6 | Option/Short | Yes/Yes | Trades | 7489 | Volume | 2,500,394 | Change | - |
뉴스 로딩 중...